Beam Therapeutics Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Beam Therapeutics Inc.
Quantité totale PI 248
Rang # Quantité totale PI 5 338
Note d'activité PI 3,2/5.0    214
Rang # Activité PI 3 157
Symbole boursier BEAM (nasdaq)
ISIN US07373V1052
Capitalisation 2,200M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

86 4
54 0
100 4
0
 
Dernier brevet 2025 - Prime editing of single base mut...
Premier brevet 2018 - Uses of adenosine base editors
Dernière marque 2023 - BEAM THERAPEUTICS
Première marque 2019 - BEAM THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Compositions and methods for editing a transthyretin gene. Compositions for gene modification re...
Invention Base editing of transthyretin gene. Provided herein are compositions for gene modification relat...
Invention Compositions and methods for cell conditioning. Compositions and methods for non-genotoxic monocl...
Invention Rna base editing compositions, systems, methods and uses thereof. The present invention provides...
Invention Synthetic polypeptides and uses thereof. Provided herein are synthetic polypeptides including tr...
Invention Nanomaterials comprising triols. The present disclosure describes compositions, preparations, na...
Invention Prime editing of single base mutations in alpha-1 antitrypsin deficiency. This disclosure provid...
Invention Prime editing of single base mutations in alpha-1 antitrypsin deficiency. SERPINA1SERPINA1 gene w...
Invention Large serine recombinases, systems and uses thereof. The present invention provides novel serine...
Invention One vector system for identification of genome modifying enzymes. The present application relate...
Invention Stable rna compositions with stem loop, and methods thereof. The present invention provides, amon...
Invention Modified allogeneic cells and methods and compositions for the preparation thereof. The present ...
Invention Compositions and methods for treating a congenital eye disease. The present disclosure features ...
Invention Compositions and methods for altering a nucleobase in a transthyretin polynucleotide. TTRTTR gene...
Invention Modified immune cells with increased resistance to allorejection. e.g.e.g., T- or NK-cells) havin...
2024 Invention Base editors with modified editing windows. Base editors with modified editing windows, such as b...
Invention Cd19-binding polypeptides, compositions comprising the same, and methods for use thereof. in vivo...
Invention Adenosine deaminase base editors and methods for use thereof. Adenosine deaminase base editors, ...
Invention Compositions and methods for reducing complement activation. Compositions and methods for reduci...
Invention Modified regulatory t cells and methods of using the same. The disclosure features modified regu...
Invention Identification of nanoparticles for preferential tissue or cell targeting. Provided herein inclu...
Invention Compositions and methods for altering complement activation. Compositions and methods for reducin...
Invention Hemoglobin g-makassar binding polypeptides and antibodies and methods of using the same. Describ...
Invention Novel rna base editing compositions, systems, methods and uses thereof. The present invention pr...
Invention Compositions and methods for altering a nucleobase in a lipoprotein(a) polynucleotide. LPALPALPA ...
Invention Compositions and methods for base editing a phenylalanine hydroxylase polynucleotide. PAHPAHPAH p...
Invention Methods of substituting pathogenic amino acids using programmable base editor systems. Provided ...
Invention Interferon inhibition with viral proteins and fragments and fusions thereof. Provided herein is a...
Invention Prime editing of single base mutations in sickle cell disease. HBB HBB gene with prime editing.
Invention Cd5-binding polypeptides, compositions comprising the same, and methods for use thereof. in vivoi...
Invention Ionizable lipids with branched head groups. The present disclosure describes compositions, prepar...
Invention Ionizable lipids with linear head groups. The present disclosure describes compositions, preparat...
Invention Modified immune effector cells with improved resistance to natural killer cell-mediated allorejec...
Invention Anti-idiotypic antibodies to cluster of differentiation 7-targeted binding domains and related co...
Invention Nanomaterials. The present disclosure describes compositions, preparations, nanoparticles (such ...
Invention Nanomaterials comprising tetravalent lipid compounds. The present disclosure describes compositi...
Invention Nanomaterials comprising diamines. The present disclosure describes compositions, preparations, ...
Invention Ionizable amine and ester lipids and lipid nanoparticles. The present disclosure describes compo...
Invention Ionizable amine lipids and lipid nanoparticles. The present disclosure describes compositions, p...
Invention Methods and compositions for treating alpha-1 antitrypsin deficiency. Compositions and methods fo...
Invention Compositions and methods for the treatment of spinal muscular atrophy (sma). The invention of th...
Invention Methods and compositions for anti-cd45 based non-genotoxic conditioning. The disclosure compositi...
Invention Compositions and methods for the treatment of hereditary angioedema (hae). The invention of the ...
Invention Compositions and methods for treating stargardt disease. ABCA4ABCA4ABCA4 gene so that the nucleot...
Invention Modified guide rna. The present invention relates to modified gRNA molecules, compositions and me...
Invention Modified immune effector cells with improved efficacy. Multiplex base edited chimeric antigen rec...
2023 Invention Circular guide rnas for crispr/cas editing systems. The present invention provides, among other ...
P/S Pharmaceutical and biological preparations based on base editing, base modification, nucleobase e...
2022 Invention Compositions and methods for genome editing the neonatal fc receptor. Provided herein are compos...
2021 Invention Fratricide resistant modified immune cells and methods of using the same. The present invention ...
2019 P/S Pharmaceutical and biological preparations based on base correction, base editing, base modifica...
P/S Scientific and medical research in the fields of base editing, base modification, base repair, nu...